Claire Cook1, April Jorge1, Xiaoqing Fu1, John Niles2, Anushya Jeyabalan2, Reza Zonozi2, John H Stone3, Yuqing Zhang1, Hyon K Choi1, Zachary S Wallace4. 1. Clinical Epidemiology Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Mongan Institute, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. 2. Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Division of Nephrology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. 3. Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. 4. Clinical Epidemiology Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Mongan Institute, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: zswallace@mgh.harvard.edu.
Abstract
OBJECTIVE: Myocardial infarction and ischemic stroke are leading causes of cardiovascular (CV) morbidity and mortality in ANCA-associated vasculitis (AAV), especially for the 20% with end-stage renal disease (ESRD). We assessed the impact of renal transplantation on the risk of myocardial infarction and stroke among patients with ESRD due to AAV. METHODS: We identified patients from the United States Renal Data System with ESRD due to AAV between 2000 and 2016. We examined the association between renal transplantation and the risk of non-fatal and fatal myocardial infarction or ischemic stroke among waitlisted patients using Medicare claims and death data through 2017. We used time-varying Cox proportional hazards models with age as the time scale to estimate hazard ratios (HR) and 95% confidence intervals (CIs) for myocardial infarction and ischemic stroke events among patients who received a renal transplant compared to those who remained on the waitlist. RESULTS: Of 1029 waitlisted patients, 593 (58%) were transplanted over a mean of 5.7 years. There were 17 events (4.6/1,000 person-years) in the transplanted group and 40 events (13.7/1,000 person-years) in the group that remained waitlisted. A renal transplant was associated with a 78% lower risk of myocardial infarction or ischemic stroke (HR=0.22, 95% CI 0.11 to 0.47). These findings persisted across sex and age groups and when censoring patients after living donor transplantation. CONCLUSIONS: Among AAV patients with ESRD, renal transplantation can substantially reduce the risk of myocardial infarction and ischemic stroke. Improving access to transplantation for this population may further improve outcomes.
OBJECTIVE: Myocardial infarction and ischemic stroke are leading causes of cardiovascular (CV) morbidity and mortality in ANCA-associated vasculitis (AAV), especially for the 20% with end-stage renal disease (ESRD). We assessed the impact of renal transplantation on the risk of myocardial infarction and stroke among patients with ESRD due to AAV. METHODS: We identified patients from the United States Renal Data System with ESRD due to AAV between 2000 and 2016. We examined the association between renal transplantation and the risk of non-fatal and fatal myocardial infarction or ischemic stroke among waitlisted patients using Medicare claims and death data through 2017. We used time-varying Cox proportional hazards models with age as the time scale to estimate hazard ratios (HR) and 95% confidence intervals (CIs) for myocardial infarction and ischemic stroke events among patients who received a renal transplant compared to those who remained on the waitlist. RESULTS: Of 1029 waitlisted patients, 593 (58%) were transplanted over a mean of 5.7 years. There were 17 events (4.6/1,000 person-years) in the transplanted group and 40 events (13.7/1,000 person-years) in the group that remained waitlisted. A renal transplant was associated with a 78% lower risk of myocardial infarction or ischemic stroke (HR=0.22, 95% CI 0.11 to 0.47). These findings persisted across sex and age groups and when censoring patients after living donor transplantation. CONCLUSIONS: Among AAV patients with ESRD, renal transplantation can substantially reduce the risk of myocardial infarction and ischemic stroke. Improving access to transplantation for this population may further improve outcomes.
Authors: R A Wolfe; V B Ashby; E L Milford; A O Ojo; R E Ettenger; L Y Agodoa; P J Held; F K Port Journal: N Engl J Med Date: 1999-12-02 Impact factor: 91.245
Authors: Anne M Murray; Stephen Seliger; Kamakshi Lakshminarayan; Charles A Herzog; Craig A Solid Journal: J Am Soc Nephrol Date: 2013-04-25 Impact factor: 10.121
Authors: Zachary S Wallace; Rachel Wallwork; Yuqing Zhang; Na Lu; Frank Cortazar; John L Niles; Eliot Heher; John H Stone; Hyon K Choi Journal: Ann Rheum Dis Date: 2018-05-14 Impact factor: 19.103
Authors: Iman O Hypolite; Jay Bucci; Paul Hshieh; David Cruess; Lawrence Y C Agodoa; Christina M Yuan; Allen J Taylor; Kevin C Abbott Journal: Am J Transplant Date: 2002-03 Impact factor: 8.086
Authors: Yuka Kiyota; Sebastian Schneeweiss; Robert J Glynn; Carolyn C Cannuscio; Jerry Avorn; Daniel H Solomon Journal: Am Heart J Date: 2004-07 Impact factor: 4.749